Panklav relates to antibiotics of penicillin in combination providing antibacterial and bactericidal effects. The drug is fast-acting and effective treatment aimed at the treatment of infectious and inflammatory diseases.  Panklav 500 mg / 125 mg

Structure and Composition

The main active substance - 250 mg amoxicillin and clavulanate potassium 125 mg.

Auxiliary components: silicon dioxide, magnesium stearate, carboxymethyl starch.

Each film-coated tablet, consisting of titanium dioxide, propylene glycol and hypromellose.

Panklav available in tablets of 125 mg and 250 mg in a plastic bottle of 20 pieces.

Pharmacological properties Panklava

Amoxicillin as the active substance has a wide spectrum of antibacterial activity against a variety of viral and bacterial infections, pathogens. Clavulanate potassium support the action of amoxicillin and strengthens its anti-inflammatory effect. The combination of active and auxiliary components Panklava provides high treatment efficiency and eliminate foci of inflammation.

Positive feedback Panklav has an effective drug with antibiotic activity against pathogens and beta-lactamase, as well as the following Gram-negative and Gram-positive bacteria: Staphylococcus epidermidis, Streptococcus pneumoniae, Bordetella pertussis, Brucella, Gardnerella vaginalis, Yersinia enterocolitica, Enterococcus, Listeria, Haemophilus influenzae etc.

Panklav has a high absorbency and is evenly distributed in the body tissues. The drug is excreted by the kidneys (mostly), intestines and lungs.

Indications Panklava

Panklav indicated for diseases caused by infections that are sensitive to its components.

The indications for admission are infectious and inflammatory diseases:

  • respiratory system and otolaryngology (bronchitis, tonsillitis, laryngitis, sinusitis, pneumonia, otitis media, etc.);
  • genitourinary system (endometritis, urethritis, pyelonephritis, gonorrhea, cystitis, etc.);
  • joints, bone and soft tissue (cellulitis, osteomyelitis, rheumatic fever, etc.);
  • biliary tract.

Instructions for use Panklava

In accordance with the instructions Panklav appointed interior adults and children from 12 years (with a body weight of at least 40 kg) - 1 tablet of 125 mg 2-3 times a day for diseases of medium difficulty.

In severe infectious and inflammatory diseases with complications Panklav assigned 3 times a day for 250-500 mg. The daily dose should not exceed 600 mg. The duration of treatment is 7-14 days, depending on the complexity of the disease.

According to the instructions Panklav should be taken with meals to minimize the side effects of the digestive system. Also during the course of treatment should monitor the general condition of the circulatory system.

Good reviews Panklav got to be an effective drug in the complex of antibiotic therapy with anticoagulants.


 Panklav 250 mg / 125 mg
 Contraindications to receiving Panklava are hypersensitivity and intolerance to the components of the drug, infectious mononucleosis type, age up to 12 years and weighing up to 40 kg, pregnancy and breastfeeding.

With careful preparation is indicated for kidney and liver failure, severe diseases of the digestive system, in old age.

Side effects Panklava

Panklav may cause the following side effects:

  • on the part of the digestive system - nausea, diarrhea, vomiting, impaired liver function. In rare cases - colitis, gastritis, hepatitis;
  • the central nervous system - headache, loss of coordination, dizziness, cramps and convulsions;
  • on the part of the genitourinary system - vaginitis, a malfunction of the kidneys, nephritis, candidiasis.

After prolonged use Panklava allergic reactions - itching, hives, skin rash, angioedema, serum sickness, erythema, pustulosis, dermatitis.